Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells

Pharmazie

Volumn 61, Issue 8, 2006, Pages 710-716

  Chen, Jie ^a   Bai, Hai ^a   Wang, Cunbang ^a   Kang, Jiuhong ^b  

^a LANZHOU GENERAL HOSPITAL   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CURCUMIN; HISTONE DEACETYLASE; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; TRICHOSTATIN A;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL DAMAGE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; LEUKEMIA;

ACETYLATION; ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; ASCORBIC ACID; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CURCUMIN; DRUG SYNERGISM; HISTONES; HL-60 CELLS; HUMANS; HYDROXAMIC ACIDS; INDICATORS AND REAGENTS; L-LACTATE DEHYDROGENASE; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROTEIN SYNTHESIS INHIBITORS; REACTIVE OXYGEN SPECIES;

EID: 33748042614     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-396.
2. Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB (2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-x1. Carcinogenesis 23: 143-150.
3. Archer SY, Hodin RA (1999) Histones acetylation and cancer. Curr Opin Gene Develop 9: 171-174.
4. Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK (2004) Curcumin, a novel p300/CBP specific inhibitor of acetyltransferase, represses the acetylation of histones/nonhistone proteins and HAT dependent chromatin transcription. J Biol Chem 279: 51163-51171.
5. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG (2001) Aberrant pattern of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10: 687-692.
6. Bhaumik S, Anjum R, Rangaraj N, Pardhasaradhi BW, Khar A (1999) Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett 456: 311-314.
7. Bielak-Zmijewska A, Koronkiewicz M, Skierski J, Piwocka K, Radziszewska E, Sikora E (2000) Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr Cancer 38: 131-138.
8. Burdon RH (1995) Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18: 775-794.
9. Chan WH, Wu CC, Yu JS (2003) Curcumin inhibits UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cells. J Cell Biochem 90: 327-338.
10. Chen J, Da WM, Zhang DW, Liu Q, Kang JH (2005) Water-soluble antioxidants improve the antioxidant and anticancer activity of low concentrations of curcumin in human leukemia cells. Pharmazie 60: 57-61.
11. Chen J, Ou YX, Da WM, Kang JH (2004) Coadjustment of quercetin and hydrogen peroxide: the role of ROS in the cytotoxicity of quercetin. Pharmazie 59: 155-158.
12. Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD, Coffey RJ (1997) Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21 WAF1/CIP1 via C/EBPβ. Nat Med 3: 1233-1241.
13. Conklin KA (2000) Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37: 1-18.
14. Cousens LS, Gallwitz D, Alberts BM (1979) Different accessibilities in chromatin to histone acetylase. J Biol Chem 254: 1716-1723.
15. Del Raso N (1992) In vitro methods for assessing chemical or drug toxicity and metabolism in primary hepatocytes. In: Watson RR (Ed.), In Vitro Methods of Toxicology. CRC Press Inc, Boca Raton, FL, pp. 176-201.
16. Deshpande SS, Irani K (2002) Oxidant signalling in carcinogenesis: a commentary. Hum Exp Toxicol 21: 63-64.
17. Donadelli M, Costanzo C, Faggioli L, Scupoli MT, Moore PS, Bassi C, Scarpa A, Palmieri M (2003) Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinogen 38: 59-69.
18. Fry CJ, Peterson CL (2002) Unlocking the gates to gene expression. Science 295: 1847-1848.
19. Galati G, Sabzevari O, Wilson JX, O'Brien PJ (2002) Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 177: 91-104.
20. Gautam SC, Xu YX, Pindolia KR, Janakiraman N, Chapman RA (1998) Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane). Biochem Pharmacol 55: 1333-1337.
21. Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389: 349-352.
22. Hadi SM, Asad SF, Singh S, Ahmad A (2000) Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life 50: 167-171.
23. He L, Tolentino T, Grayson P, Zhong S, Warrell RP, Rifkind RA, Marks PA, Richon VM, Pandolfi PP (2001) Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest 108: 1321-1330.
24. Hendersona C, Brancolini C (2003) Apoptotic pathways activated by histone deacetylase inhibitors: implications for the drug-resistant phenotype. Drug Resist Updates 6: 247-256.
25. Joe B, Lokesh BR (1994) Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1224: 255-263.
26. Kang J, Chen J, Shi Y, Jia J, Zhang Y (2005) Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol 69: 1205-1213.
27. Kang J, Chen J, Zhang D, Da W, Ou Y (2004) Synergistic killing of human leukemia cells by antioxidants and trichostatin A. Cancer Chemother Pharmacol 54: 537-545.
28. Kang JH, Shi YM, Zheng RL (1999) Effects of ascorbic acid on human hepatoma cell proliferation and redifferentiation. Acta Pharmacol Sin 20: 1019-1024.
29. Kang JH, Shi YM, Zheng RL (2000) Effects of ascorbic acid and DL-alpha-tocopherol on human hepatoma cell proliferation and redifferentiation. Acta Pharmacol Sin 21: 348-352.
30. Kang JH, Wei YM, Zheng RL (2001) Effects of diethyldithiocarbamate on proliferation, redifferention, and apoptosis in human hepatoma cells. Acta Pharmacol Sin 22: 785-792.
31. Khar A, Ali AM, Pardhasaradhi BV, Varalakshmi CH, Anjum R, Kumari AL (2001) Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: role of reactive oxygen intermediates. Cell Stress Chaperones 6: 368-376.
32. Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F (2003) Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 63: 7291-7300.
33. Kim MS, Kang HJ, Moon A (2001) Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. Arch Pharm Res 24: 349-354.
34. Klochendler-Yeivin A, Yaniv M (2001) Chromatin modifiers and tumor suppression. Biochim Biophys Acta 1551: M1-M10.
35. LeBel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 29,79-dichlorofluorescein as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5: 227-231.
36. Lehrmann H, Pritchard LL, Harel-Bellan A (2002) Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation. Adv Cancer Res 86: 41-65.
37. Marks PA, Richon VM, Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Nat Cancer Inst 92: 1210-1216.
38. Marks PA, Richon VM, Breslow R, Rifkind RA (2001) Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 13: 477-483.
39. Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1-15.
40. McCord JM (1998) The importance of oxidant-antioxidant balance. In: Montagnier L et al. (ed.) Oxidative stress in cancer, AIDs and neurodegenerative diseases, New York, p. 1-6.
41. Nogaki A, Satoh K, Iwasaka K, Takano H, Takahama M, Ida Y, Sakagami H (1998) Radical intensity and cytotoxic activity of curcumin and gallic acid. Anticancer Res 18: 3487-3491.
42. Park CH, Amare M, Savin MA, Hoogstraten B (1980) Growth suppression of human leukemic cells in vitro by L-ascorbic acid. Cancer Res 40: 1062-1065.
43. Park CH, Kimler BF (1991) Growth modulation of human leukemic, preleukic, and myeloma progenitor cells by L-ascorbic acid. Am J Clin Nutr 54: 1241S-1246S.
44. Prasad KN, Hernandez C, Edwards-Prasad J, Nelson J, Borus T, Robinson WA (1994) Modification of the effect of tamoxifen, cisplatin, DTIC and interferon-2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer 22: 233-245.
45. Rosato RR, Grant S (2003) Histone deacetylase inhibitors in cancer therapy. Cancer Biol Ther 2: 30-37.
46. Roy M, Chakraborty S, Siddiqi M, Bhattacharya RK (2002) Induction of apoptosis in tumor cells by natural phenolic compounds. Asian Pac J Cancer Prev 3: 61-67.
47. Sakano K, Kawanishi S (2002) Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes. Arch Biochem Biophys 405: 223-230.
48. Wang P, Kang J, Zheng R, Yang Z, Lu J, Gao J, Jia Z (1996) Scavenging effects of phenylpropanoid glycosides from Pedicularis on superoxide anion and hydroxyl radical by the spin trapping method. Biochem Pharmacol 51: 687-691.
49. Wedgwood S, Black SM (2003) Induction of apoptosis in fetal pulmonary arterial smooth muscle cells by a combined superoxide dismutase/catalase mimetic. Am J Physiol Lung Cell Mol Physiol 285: L305-312.
50. Wroblewski F, La Due J (1995) Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 90: 210-213.
51. Yamashita Y, Shimada M, Harimoto N, Rikimaru T, Shirabe K, Tanaka S, Sugimachi K (2003) Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer 103: 572-576.